Nelson MV - Search Results

1

Nelson MV. Nelson MV. Br Dent J. 2005 May 28;198(10):628. doi: 10.1038/sj.bdj.4812376. Br Dent J. 2005. PMID: 15920594 No abstract available.

2

The wrong direction?

Nelson MV. Nelson MV. Br Dent J. 2012 Mar 9;212(5):205-6. doi: 10.1038/sj.bdj.2012.179. Br Dent J. 2012. PMID: 22402520 No abstract available.

3

Dental education: What are we going to do about it?

Nelson MV. Nelson MV. Br Dent J. 2015 Nov 27;219(10):470. doi: 10.1038/sj.bdj.2015.866. Br Dent J. 2015. PMID: 26611287 No abstract available.

4

OMFS: Notation confusion.

Nelson MVB. Nelson MVB. Br Dent J. 2017 Jul 7;223(1):3. doi: 10.1038/sj.bdj.2017.559. Br Dent J. 2017. PMID: 28684827 No abstract available.

5

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.

Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Nelson MV, et al. Oncologist. 2024 Aug 5;29(8):723-e1093. doi: 10.1093/oncolo/oyae119. Oncologist. 2024. PMID: 38873934 Free PMC article. Clinical Trial.

6

Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.

Liu Y, Nelson MV, Bailey C, Zhang P, Zheng P, Dome JS, Liu Y, Wang Y. Liu Y, et al. Among authors: nelson mv. Oncogene. 2022 Feb;41(9):1383. doi: 10.1038/s41388-021-02042-7. Oncogene. 2022. PMID: 35046533 No abstract available.

7

Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.

Liu Y, Nelson MV, Bailey C, Zhang P, Zheng P, Dome JS, Liu Y, Wang Y. Liu Y, et al. Among authors: nelson mv. Oncogene. 2021 Jul;40(29):4809-4819. doi: 10.1038/s41388-021-01907-1. Epub 2021 Jun 21. Oncogene. 2021. PMID: 34155347 Free PMC article.

8

New approaches to risk stratification for Wilms tumor.

Nelson MV, van den Heuvel-Eibrink MM, Graf N, Dome JS. Nelson MV, et al. Curr Opin Pediatr. 2021 Feb 1;33(1):40-48. doi: 10.1097/MOP.0000000000000988. Epub 2020 Dec 29. Curr Opin Pediatr. 2021. PMID: 33394739 Free PMC article. Review.

9

Collaboration across the pond: the multi-school progress testing project.

Swanson DB, Holtzman KZ, Butler A, Langer MM, Nelson MV, Chow JW, Fuller R, Patterson JA, Boohan M, The Multi-School Progress Testing Committee. Swanson DB, et al. Among authors: nelson mv. Med Teach. 2010;32(6):480-5. doi: 10.3109/0142159X.2010.485655. Med Teach. 2010. PMID: 20515377

10

Corticosteroid resistance in eosinophilic gastritis--relation to in vitro eosinophil survival and interleukin 5.

Quan SF, Sedgwick JB, Nelson MV, Busse WW. Quan SF, et al. Among authors: nelson mv. Ann Allergy. 1993 Mar;70(3):256-60. Ann Allergy. 1993. PMID: 8452321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters